3m5m
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
| - | [[Image:3m5m. | + | [[Image:3m5m.png|left|200px]] |
<!-- | <!-- | ||
| Line 12: | Line 12: | ||
===Avoiding drug resistance against HCV NS3/4A protease inhibitors=== | ===Avoiding drug resistance against HCV NS3/4A protease inhibitors=== | ||
| + | |||
| + | <!-- | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_21084633}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 21084633 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_21084633}} | ||
==About this Structure== | ==About this Structure== | ||
3M5M is a 3 chains structure with sequences from [http://en.wikipedia.org/wiki/Hepatitis_c_virus_subtype_1a Hepatitis c virus subtype 1a]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3M5M OCA]. | 3M5M is a 3 chains structure with sequences from [http://en.wikipedia.org/wiki/Hepatitis_c_virus_subtype_1a Hepatitis c virus subtype 1a]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3M5M OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:21084633</ref><references group="xtra"/> | ||
[[Category: Hepacivirin]] | [[Category: Hepacivirin]] | ||
[[Category: Hepatitis c virus subtype 1a]] | [[Category: Hepatitis c virus subtype 1a]] | ||
| Line 29: | Line 38: | ||
[[Category: Serine protease]] | [[Category: Serine protease]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec 22 09:27:39 2010'' |
Revision as of 06:15, 22 December 2010
Avoiding drug resistance against HCV NS3/4A protease inhibitors
Template:ABSTRACT PUBMED 21084633
About this Structure
3M5M is a 3 chains structure with sequences from Hepatitis c virus subtype 1a. Full crystallographic information is available from OCA.
Reference
- Romano KP, Ali A, Royer WE, Schiffer CA. Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding. Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):20986-91. Epub 2010 Nov 17. PMID:21084633 doi:10.1073/pnas.1006370107
Page seeded by OCA on Wed Dec 22 09:27:39 2010
